University of Basel

Department of
Biomedicine

Search

News

RSS
Stock Image
/ News, Research

Exploring the Impact of Drugs on Cellular Metabolism (Zampieri Lab)

Researchers in Mattia Zampieri's Systems Pharmacology and Biology of Metabolism lab have developed a novel method to study how thousands of active compounds simultaneously affect cellular metabolism. This approach offers new insights into…

.
/ News, People

Two SNSF Advanced Grants for the Department of Biomedicine

Cancer researcher Prof. Dr. Mohamed Bentires-Alj and diabetes researcher Prof. Dr. Marc Donath have each been awarded one of the highly competitive grants from the Swiss National Science Foundation (SNSF). Both projects address socially…

CD52-stabilization as a potential target for immunotherapy in liver cirrhosis. (Symbolic image: ChatGPT)
/ News, Research

Unveiling CD52 on monocytes: A New Frontier in Combating Immune Dysfunction in Cirrhosis (Bernsmeier Lab)

The Department of Biomedicine (DBM) is pleased to announce an important new study led by Anne Geng, under the supervision of Christine Bernsmeier, in collaboration with researchers at the University Hospital Basel and colleagues in St.…

Swiss Cancer Research and League
/ News, Research

Advancing Cancer Research: Our Scientists Secure Prestigious Grant for Groundbreaking Project

The Swiss Cancer Research Foundation and the Swiss Cancer League have recently announced the recipients of their latest funding round, awarding grants to 55 outstanding research projects in various categories. We are proud to announce that…

.
/ News, Other

For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin (Jeker Lab)

Start-up Cimeio Therapeutics intends to pave the way for gentler and more efficient treatments for diseases such as blood cancer. The company, a spin-off of the University of Basel, has just concluded an important collaboration agreement:…

Social Media

To top